We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Tackle Industry Concerns With First Biosimilars Meeting
FDA to Tackle Industry Concerns With First Biosimilars Meeting
October 12, 2010
The FDA may end its silence on how an approval pathway for biosimilars will work once it gets feedback at its first public meeting on the topic next month.